Skip to main content
. 2015 Apr 30;14(13):2142–2148. doi: 10.1080/15384101.2015.1041689

Table 2.

Prostate cells used in this study

Cell line Tumorigenicity Androgen sensitivity AR PTEN p53
RWPE-1 N/A Sensitive + WT WT
LNCaP Very low Sensitive + Mutant WT
C4-2 Moderate Insensitive + Mutant WT
PC3 High Insensitive Null Null
22Rv-1 Low Sensitive Variants WT Mutant